Vertex Pharmaceuticals Incorporated VRTX Casgevy Commercial Momentum and Pipeline Catalysts Signal Upside Ahead of Partner CRISPR Therapeutics Q1 2026 Earnings VBNK VersaBank posts 131 percent Q1 2026 EPS miss as net interest margin pressures crimp quarterly profitability Is Real Asset RAAQ stock forming higher highs